Related Experiment Video
Updated: Jun 27, 2026

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Akkermansia Muciniphila-Inspired Oral siRNA Delivery by Active Matrix-Penetration and Intracellular Endoplasmic
Chao Pan1,2, Yang Wang1,3, Min Zhang1,2,4
1State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, P. R. China.
Abstract:
Oral delivery of small interfering ribonucleic acid (siRNA) is highly challenging due to the multiple barriers present in the gastrointestinal tract and within cells. Herein, inspired by intestinal Akkermansia muciniphila, the use of Akkermansia muciniphila membrane vesicles (AMVs) is introduced as an effective tool for oral delivery of siRNA. It is revealed that, distinct from common passive mucus-penetrating nanoparticles, AMVs enable active mucus penetration by degrading intestinal mucins, thereby enhancing their ability to traverse the intestinal barrier by approximately 4.6 times. Additionally, AMVs can markedly heighten siRNA penetration into tumor tissues. Once inside tumor cells, AMVs bypass the traditional endosomal-lysosomal degradation pathway typical of lipid-based delivery systems. Instead, they utilize a rapid transport expressway from the Golgi apparatus to the endoplasmic reticulum (ER), facilitating the accumulation of siRNA within the ER and thereby markedly enhancing gene silencing efficiency. In a mouse model of colorectal cancer, this formulation effectively inhibits tumor growth by 91.6%, and it exhibits a favorable biosafety profile. Overall, this research unveils a unique and promising bioinspired platform for oral siRNA delivery, advancing the development of safe and efficient oral nucleic acid therapeutics.
Insights
Inspired by gut bacteria, Akkermansia muciniphila membrane vesicles (AMVs) offer a novel oral delivery method for small interfering ribonucleic acid (siRNA). This bioinspired approach enhances mucus penetration and tumor delivery, improving gene silencing and inhibiting cancer growth.
Area of Science:
- Biotechnology
- Nanomedicine
- Drug Delivery
Background:
- Oral delivery of small interfering ribonucleic acid (siRNA) faces significant challenges due to gastrointestinal and cellular barriers.
- Current delivery systems often struggle with effective mucus penetration and intracellular transport.
Purpose of the Study:
- To develop a novel, bioinspired platform for effective oral siRNA delivery.
- To leverage Akkermansia muciniphila membrane vesicles (AMVs) for enhanced therapeutic efficacy.
Main Methods:
- Utilized Akkermansia muciniphila membrane vesicles (AMVs) for siRNA encapsulation and oral delivery.
- Investigated AMV interaction with intestinal mucins for mucus penetration.
- Assessed intracellular trafficking and gene silencing efficiency in tumor cells.
- Evaluated tumor growth inhibition and biosafety in a colorectal cancer mouse model.
Main Results:
- AMVs demonstrated active mucus penetration by degrading mucins, improving intestinal barrier traversal by 4.6 times.
- AMVs significantly enhanced siRNA penetration into tumor tissues.
- AMVs facilitated siRNA accumulation in the endoplasmic reticulum, bypassing endosomal-lysosomal degradation and improving gene silencing.
- Achieved 91.6% inhibition of tumor growth in a colorectal cancer model with a favorable safety profile.
Conclusions:
- Akkermansia muciniphila membrane vesicles (AMVs) represent a promising bioinspired platform for oral siRNA delivery.
- This approach overcomes key barriers to oral nucleic acid therapeutics, enhancing efficacy and safety.
- Further development of AMV-based systems could advance oral gene silencing therapies.
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Experimental RNAi
The Antiviral System of Bacteria and Archaea: CRISPR
Bacteriophages of the Human Virome

